Aligos Therapeutics (NASDAQ:ALGS) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Aligos Therapeutics to report an earnings per share (EPS) of $-2.97.

Anticipation surrounds Aligos Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Past Earnings Performance

Last quarter the company missed EPS by $9.41, which was followed by a 0.96% increase in the share price the next day.

Here's a look at Aligos Therapeutics's past performance and the resulting price change:

Market Performance of Aligos Therapeutics's Stock

Shares of Aligos Therapeutics were trading at $5.6 as of May 02. Over the last 52-week period, shares are down 74.71%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Aligos Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.